2021 annual financial data
Barinthus Biotherapeutics 2021 Operating margin
Direct answer
Operating margin was -16,873.51%.
Operating income was -45,221,000 USD and net income was -50,865,000 USD.
Operating cash flow was -32,583,000 USD.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 268,000 USD
- Operating income
- -45,221,000 USD
- Net income
- -50,865,000 USD
- Operating cash flow
- -32,583,000 USD